Overview

Evaluation of Safety and Efficacy of Estetrol in Healthy Men

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The current study is designed as a phase Ib multiple dose study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of E4 in healthy men after daily oral administration for 28 days.
Phase:
Phase 1
Details
Lead Sponsor:
Pantarhei Oncology B.V.